US · Healthcare

Ravenquest Biomed Inc (RVVQF)

Drug Manufacturers - Specialty & Generic

Ravenquest Biomed Inc (RVVQF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RVVQF

P/E ratio

18.00

Ravenquest Biomed Inc (RVVQF) — FAQ

What is RVVQF's P/E ratio?

The price-to-earnings (P/E) ratio for Ravenquest Biomed Inc (RVVQF) is 18.00 (data as of 2026-05-23).

Does Ravenquest Biomed Inc pay a dividend?

Dividend yield is not available in the current snapshot for Ravenquest Biomed Inc (RVVQF). Check the MyAverix Finance app for the latest dividend data.

What sector is Ravenquest Biomed Inc in?

Ravenquest Biomed Inc (RVVQF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is RVVQF listed on?

RVVQF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)